<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Administration of <z:chebi fb="0" ids="45652">succinylcholine</z:chebi> to <z:mpath ids='MPATH_458'>normal</z:mpath> individuals results in alterations in muscle membrane integrity expressed as a slight increase in the concentrations of <z:chebi fb="2" ids="16919">creatine</z:chebi> phosphokinase (CK) in serum and appearance of small amounts of <z:chebi fb="2" ids="7044">myoglobin</z:chebi> in the urine, but without clinical symptoms </plain></SENT>
<SENT sid="1" pm="."><plain>Subjects with <z:hpo ids='HP_0000486'>strabismus</z:hpo> due to <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> may develop more significant <z:hpo ids='HP_0003201'>rhabdomyolysis</z:hpo> expressed as <z:hpo ids='HP_0003552'>muscle stiffness</z:hpo> and <z:mp ids='MP_0000746'>weakness</z:mp>, massive <z:hpo ids='HP_0002913'>myoglobinuria</z:hpo>, marked elevation of serum CK and other enzymes, <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo>, <z:hpo ids='HP_0001649'>tachycardia</z:hpo> and moderate elevation of body temperature </plain></SENT>
<SENT sid="2" pm="."><plain>In some cases grave <z:hpo ids='HP_0002047'>malignant hyperthermia</z:hpo> with significant <z:mp ids='MP_0005039'>hypoxia</z:mp>, <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo>, <z:hpo ids='HP_0001649'>tachycardia</z:hpo> and marked abnormalities in serum electrolyte concentrations may cause irreversible damage to the central <z:mp ids='MP_0008912'>nervous</z:mp> system and other vital organs and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A case of difficult anaesthesia for a six year old boy belonging to family affected with <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> is presented </plain></SENT>
<SENT sid="4" pm="."><plain>More attention must be given to preoperative examination (anamnesis, serum enzymes) or ophthalmological patients and more careful monitoring during anaesthesia and in the early postoperative period must be instituted to prevent and treat complications induced by <z:chebi fb="0" ids="45652">succinylcholine</z:chebi> and volatile <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> agents </plain></SENT>
</text></document>